Compugen quadruples revenue
Drug discovery platform developer Compugen Ltd. almost quadrupled its revenue to $800,000 for the second quarter of 2010 from $225,000 for the corresponding quarter of 2009 thanks to the recognition of initial fees and research revenues from collaborative ventures.
Demand for cars and trucks is set to quadruple by 2035 if current trends continue, new research has claimed.